Hello Anonymous,
You raised two questions relating to clinical investigations, one concerning misuse during a clinical investigation and the other when use error does not harm the patient or caused injuries and therefore the clinical team does not believe it's a complaint. The clinical team is correct. Under the internationally recognized standard for medical device clinical investigations, ISO 14155:2011, what you are describing should be treated as a device deficiency, unless the device is being studied in the post-market period and has been released for distribution (US Quality System Regulation) or released from the organization's control (ISO 13485:2016). That is, if the device being studied is not yet on the market (here I am limiting this circumstance to the US and Europe), device deficiencies identified during a clinical investigation are not complaints.
Clause 3.15 of ISO 14155:2011 defines "device deficiency" as "inadequacy of a medical device with respect to its identity, quality, durability, reliability, safety or performance. NOTE Device deficiencies include malfunctions, use errors, and inadequate labelling."
Clause 6.4.2 of ISO 14155:2011 states: "All device deficiencies related to the identity, quality, durability, reliability, safety or performance of an investigational medical device shall be documented throughout the clinical investigation and appropriately managed by the sponsor." The rest of the clause addresses device deficiencies that require reporting.
According to ISO 14155:2011, which is a European harmonized standard and an FDA recognized standard, when use errors occur during a clinical investigation, they need to be documented and managed by the sponsor in a manner that is appropriate to the use error, which of course, could be due to the design of the device, its labeling, need for user to be trained, etc.
The European Medical Device Regulation (EU 2017/745) has adapted the definition of "device deficiency" from ISO 14155 in Article 2(59) to be "…any inadequacy in the identity, quality, durability, reliability, safety or performance of an investigational device, including malfunction, use errors or inadequacy in information supplied by the manufacturer."
The US Investigational Device Exemption (21 CFR Part 812) regulation states only that records concerning adverse device effects (whether anticipated or unanticipated) and complaints must be maintained. There is no further comment about "complaints," which as stated above, are alleged deficiencies of a device after it is released for distribution.
I hope this helps!
------------------------------
Maria E Donawa, M.D.
President, Donawa Lifescience Consulting Srl
Rome, Italy
medonawa@donawa.com+39 06 578 2665
------------------------------
Original Message:
Sent: 25-Jun-2019 16:01
From: Anonymous Member
Subject: Complaint handling process
This message was posted by a user wishing to remain anonymous
Hi all,
Say a device has been released for customer to use, our engineer notice a user error while observing the customer using the device, and reported back to the company. Does that count as complaint? Should it be handled differently as it's not a complaint coming directly from the customer.
Thanks.